Skip to main content
Erschienen in: BMC Infectious Diseases 1/2022

Open Access 01.12.2022 | Research

Analysis of metabolites of fungal balls in the paranasal sinuses

verfasst von: Xiaoqing Zhang, Na Zhang, Qian Huang, Shunjiu Cui, Lingyan Liu, Bing Zhou

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2022

Abstract

Fungal ball sinusitis is characterized by complex fungus infections with non-invasive inflammation. But no research reported fungal ball composition and metabolic-related product types currently. 12 patients with chronic rhinosinusitis who underwent surgery and 9 healthy control were enrolled in this study. Samples from both groups were analyzed for high-throughput metabolites by UPLC-MS. OsiriX software was applied to perform imaging measurements on sinus CT. 2138 and 394 metabolites were screened from cationic and anionic modes. There was a significant difference in the abundance of glycerophospholipid metabolism and sphingolipid metabolism between the two groups, with the experimental group showing an increased trend related to the sphingolipid metabolic pathway, including sphingosine 1-phosphate (S1P) and related products, diacylglycerol, sphingomyelin (SM), suggesting that its metabolites are associated with mucosal and bony inflammation. Imaging measurements showed a median sinus CT value (median (P25, P75) of 351(261.4, 385.8) HU and a median sinus wall thickness (median (P25, P75) of 2.31(1.695, 3.718) mm, which correlated with the levels of glycerophospholipid metabolites and sphingolipid metabolites (P < 0.03). Dysfunctional glycerophospholipid and sphingolipid metabolism is present in the lesion of fungal ball sinusitis. Glycerophospholipid and sphingolipid metabolism plays a significant role in the progression of mucosal and osteitis produced by fungal ball sinusitis.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
Cer
Ceramide
CL
Cardiolipin
CT
Computed tomography
DG
Diacylglycerol
DihCer
Dihydroceramide
DiSPH
Dihydrosphingosine
HMDB
Human Metabolome Database
HU
Hounsfield Unit
KEGG
Kyoto Encyclopedia of Genes and Genomes
LysoPC
Lysophosphatidylcholine
MRI
Magnetic resonance imaging
PC
Phosphocholine
PE
Phosphatidylethanolamine
PG
Phosphatidylglycerol
PGP
Phosphatidylglycerophosphate
PS
Phosphatidylserine
S1P
Sphingosine-1-phosphate
SM
Sphingomyelin
SPH
Sphingosine
UPLC/MS
Ultra-performance liquid chromatography coupled to mass spectrometry

Introduction

The fungal ball of the paranasal sinus is defined as a non-invasive accumulation of dense fungi in the sinus cavity, most often in the maxillary sinus [1]. Clinical symptoms are nonspecific, including nasal discharge, nasal obstruction, headache, and facial pain [2]. Computed tomography (CT) and magnetic resonance imaging (MRI) have more characteristic performances. CT shows a high-density area, sclerosis of the lateral sinus wall, erosion of the inner sinus wall, and irregular material surface. MRI illustrated a low-intensity area on T2-weighted MR imaging. Imaging examinations indicated high sensitivity and specificity [35], suggesting potential mucosa and bone inflammation factors. In the previous studies, the pathogenesis of fungal sinusitis was related to innate mucosal immunity. The fungal colonization pattern molecules continued stimulating the pattern recognition receptors, which activated innate immune cells to synthesize many innate immune molecules. In this way, the apical junction complex in the nasal mucosa of immunodeficient or potentially immunodeficient individuals and atopic individuals exacerbated fungal antigen exposure. As a result, the innate and adaptive immune was triggered and failed [68]. Toll-like receptors (TLRs) and C-type lectin-like receptors (CLRs) detect fungal components and activate epithelial cells to release innate inflammatory cytokines including interleukin (IL)-1b, IL-25, IL-33, and thymic stromal lymphopoietin (TSLP). Th2 cells cause eosinophil recruitment, goblet cell hyperplasia, mucus production, and antigen-specific IgE synthesis by secreting IL-4, IL-5, and IL-13 in response to fungal antigens, hence defining type 2 adaptive immune responses [9, 10]. However, there is still a lack of large-scale prospective studies on the pathogenesis of fungal sinusitis, and there is no unified conclusion.
Metabolomics provides the potential to analyze biochemical changes in disease pathology. As the use of metabolomics technology continues to evolve in all drug discovery and development areas, its range of applications continues to expand, and its impact is rapidly expanding [11]. Involving detailed experimental analysis of the metabolic profile, the level of detection can be considered the final response of the biological system, reflecting the overall outcome of the natural event. UPLC/MS (Ultra-performance liquid chromatography coupled to mass spectrometry) is an advanced analytical technology supporting metabolomics and has evolved into a sensitive and highly reproducible platform for the simultaneous determination of hundreds of metabolites [12], widely used in metabolomics research. Nowadays, metabolomics has been commonly used in the study of immune regulation in the intestinal mucosa, but studies in upper airway diseases are relatively limited.
To the best of our knowledge, there are currently no related articles reporting fungal ball composition and metabolic-related product types. Therefore, the objective of this study is to determine the relationship between the composition of the fungal ball and the development of the disease pathogenesis by exploring the metabolic components and to explore the relationship between the composition and clinical features.

Patients and methods

Participants

The population comprised 12 adults with fungal balls patients in the maxillary sinus and 9 healthy control. The institutional review board approved the protocol (2019A057) and consent was obtained from all subjects. Demographic patient data and results of serum biochemical examination were recorded. Exclusion criteria included: (1) endoscopic sinus surgery history; (2) severe nasal or maxillofacial trauma history; (3) combined other diseases sinus diseases, including chronic bacterial sinusitis, nasal polyps, tumors, or atopic inflammation; (4) respiratory infection in 3 months; (5) systemic metabolic bone diseases, including diabetes and immunosuppression; (6) applied steroid nasal spray, oral methylprednisolone, antibiotics or immunosuppressants in 2 weeks. Each patient in the research group received ESS from authors Q.H. and S.C, which procedure has been described by Kennedy [13, 14]. With a 0° endoscope, uncinate process resection and anterior ethmoidectomy were conducted, and maxillary sinusotomy was performed at 70° endoscope. 4 mm, 40°/60° microdebriders were used in all cases.

Sample collection

For the fungal balls patients’ group, samples were immediately obtained during surgery and frozen (− 80°). For the healthy control group, secretion was taken from the middle nasal meatus: a swelling sponge (3.5 × 0.9 × 0.4 cm) was cut into 8 equal portions, and 2 of 8 were placed in healthy control individuals’ middle nasal meatus for 10 min. After taking it out, the two tiny swelling sponges were immersed in 1 ml of 0.9% sodium chloride solution at 4 °C for 2 h and centrifuged at 1500g for 15 min at 4 °C. The centrifuged liquid was kept frozen (− 80°) as well. All individuals had twice-daily nasal irrigation for 3 days before collecting samples.

UPLC-MS experiments

Each frozen sample was thawed, and a 50 ± 5 mg aliquot was mixed with 1.5 ml 100% methanol (methanol: water = 1:1) in a 2 ml micro-centrifuge tube. The mixture was shaken for 1 h and then centrifuged for 10 min. The precipitation and supernatant were collected for each sample. Then a total of 1.6 ml of methanol and dichloromethane (1:3) was added to the precipitate. Every sample was vibrated and sonicated for 1 h, then centrifuged to obtain the supernatant. The supernatant from both steps was combined and then dried under nitrogen gas flow. Before UPLC-MS analysis, the dried extract was reconstituted in 100 μl (methanol: MS-grade water = 1:1), and centrifuged again to remove any insoluble residuals. Finally, the supernatant was transferred to a sampling bottle. A schematic diagram of the experimental procedures is shown in Fig. 1.

CT measurement

The anatomical dimensions of all patients were measured using an OsiriX® (Pixmeo, Geneva, Switzerland) viewer in combination with preoperative 3D CT software. Reconstruction parameters and methods such as window width, window level, and head position normalization are consistent with previous studies (Brilliance 64 CT machine, Philips Medical System, Cleveland, OH; scan parameters: 120 kV; 300 mA; matrix size 512 × 512; axial slice thickness 1 mm; window width: × 4000 Hounsfield units (HU); window level: 700 HU) [15, 16].
From the axial view, two dimensions were measured (Fig. 2): (1) thickness of the posterior lateral wall of the maxillary sinus (Fig. 2a); the posterior lateral wall of the maxillary sinus was chosen because it is the most fixed area in the maxillary sinus CT image. (2) The highest CT value of the high-density area in the maxillary sinus (Fig. 2b). The measurement was 3 times and took the average value.

Data analysis

UPLC-MS data were processed by Progenesis QI 2.0 software and Ezinfo 3.0 (Waters), which performed automatic baseline correction, alignment, and peak peaking. The peaks of missing values were removed by the 80% rule [14]. Selected peak indices with accurate m/z and segmentation information were submitted to online library searches, including Human Metabolome Database (HMDB), Kyoto Encyclopedia of Genes and Genomes (KEGG), ChemSpider, and LipidMAPS. Statistical analysis was performed by SPSS 21 software (SPSS Inc., Chicago, IL), including the Kolmogorov–Smirnov test, Student’s t-test or Mann–Whitney U test, and correlation analysis.

Result

Patient characteristics

A total of 12 fungal balls in the maxillary sinus and 9 healthy control who satisfied the inclusion and exclusion criteria were enrolled. There was no significant difference in age and gender between the two groups. Details are shown in Table 1.
Table 1
Clinical information of fungal ball patients and healthy control
Characteristics
Fungal ball patients
Healthy controls
Amount
12
9
Age, mean ± SD years
52.5 ± 12.39
50.3 ± 10.28
Gender, male:female
3:9
3:6
Specimen side, right:left
6:6
4:5

Metabolic differences of follicular fluid between fungal ball sinusitis and controls

A total of 21 samples were analyzed with a random sequence under both positive and negative ion modes. The 80% rule was applied to remove the missing value after peak alignment. Orthogonal signal correction partial least statistical analysis (OPLS) was utilized to summarize the most significant population differences in complex multivariate data. A total of 2138 and 394 compound signals were reserved in ESI positive and ESI negative modes, respectively. The p-values were corrected with Benjamini & Hochberg method.
Compound signals with VIP greater than 1 were selected to further screen metabolites by searching databases including KEGG, HMDB, and ChemSpider. The more rigorous filtering strategy was applied: (a) corrected p < 0.05; (b) MS fragment patterns involved in library search; (c) library (HMDB) search score > 40. Finally, twenty-six metabolites with p < 0.05 were retained and presented in Table 2.
Table 2
UPLC-MS detected metabolites that varied in PCOS fungal sinusitis with significant difference (corrected p < 0.05)
Metabolite
m/z
Mass error (ppm)
PCOS vs controlc
p-value
(B-H corrected)
HMDB /
ChemSpider ID
Class
Phytosphingosine
318.300a
− 0.53
2.1E−02
HMDB0004610
Organonitrogen compounds
LysoPC(18:1(11Z))
544.3354a
− 4.14
9.9E−03
HMDB0010385
Glycerophospholipids
PE (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
776.5623a
4.37
1.1E−04
HMDB0009684
Glycerophospholipids
Tryptophanol
184.0728a
− 3.29
1.1E−05
HMDB0244977
Indoles and derivatives
N-hexadecanoylsphinganine-1-phosphocholine
703.57161a
− 4.60
1.1E−05
HMDB0062665
Sphingolipids
SM(d18:1/18:0)
813.6819a
− 3.07
3.8E−05
HMDB0062559
Sphingolipids
Lactosylceramide (d18:1/24:1(15Z))
994.7175a
− 1.70
1.5E−04
HMDB0004872
Sphingolipids
PC(O-16:0/18:2(9Z,12Z)
786.5988a
− 2.43
1.1E−02
HMDB0011151
Glycerophospholipids
PC(O-16:0/0:0)
963.7126a
− 1.124
1.4E−03
CSID142380
Glycerophospholipids
PC(DiMe(11,3)/MonoMe(11,3))
853.5844a
2.06
7.2E−07
HMDB0061395
Glycerophospholipids
Galabiosylceramide (d18:1/16:0)
862.6238b
− 1.41
4.3E−04
HMDB0004833
Sphingolipids
dl-Mevalonic acid
319.13698a
2.14
1.0E−05
HMDB0006024
Fatty acyls
Diacylglycerol
729.5670a
0.83
1.0E−03
HMDB0242173
Glycerolipids
Harman
365.1777a
4.45
6.0E−06
HMDB0035196
Alkaloids
PS(14:1(9Z)/14:0)
700.4173a
1.91
8.0E−07
HMDB0012341
Glycerophospholipids
PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
869.5322a
2.26
7.6E−08
HMDB0116601
Glycerophospholipids
PGP(i-13:0/a-25:0)
909.5572a
− 2.33
7.1E−06
HMDB0116553
Glycerophospholipids
CL(8:0/13:0/17:0/18:2(9Z,11Z))
1259.8071a
1.70
4.0E−04
HMDB0119867
Glycerophospholipids
N-lactoyl-Tryptophan
299.1006a
1.34
2.9E−04
HMDB0062178
Carboxylic acids and derivatives
Ganglioside GM3 (d18:0/12:0)
1099.6683a
− 4.73
2.1E−06
HMDB0011913
Glycosphingolipids
l-Phenylalanine
166.0863a
0.25
6.5E−03
HMDB0000159
Carboxylic acids and derivatives
PGP(18:3(9Z,12Z,15Z)/16:0)
823.4563b
3.80
4.7E−04
HMDB0013577
Glycerophospholipids
LysoPC(0:0/18:2(9Z,12Z))
542.3214a
− 2.86
1.2E−02
HMDB0061700
Glycerophospholipids
Tenuazonic acid
395.2179a
0.58
5.9E−13
HMDB0036074
Pyrrolines (Fungal toxins)
Farnesyl pyrophosphate
383.1399a
4.17
1.3E−03
HMDB0000961
Prenol lipids
1-Oleoylglycerophosphoinositol
599.3181a
− 1.66
7.7E−15
HMDB0061693
Glycerophospholipids
aMetabolites were detected in positive ion mode; bmetabolites were detected in negative ion mode; cArrows indicate increase (↑) or decrease (↓) in the fungal balls compared with secretion of healthy people
From ESI positive mode, levels of LysoPC (Lysophosphatidylcholine, Substituents: 1-acyl-sn-glycero-3-phosphocholine), PE (phosphatidylethanolamine), PC (phosphocholine), 2-linoleoyl-sn-glycero-3-phosphocholine (Substituents: 2-acyl-sn-glycero-3-phosphocholine) in patients with fungal balls sinusitis were increased, while levels of PS (phosphatidylserine), PG (phosphatidylglycerol), PGP (phosphatidylglycerophosphate), CL (cardiolipin) showed decreased. All sphingolipids indicated significantly higher than healthy controls, including N-hexadecanoylsphinganine-1-phosphocholine (Sphingoid-1-phosphate or derivatives), Sphingomyelin, Lactosylceramide, Galabiosylceramide, Phytosphingosine.

Disturbance in metabolism of fungal balls

The online resource MetPA was utilized to locate metabolites in pathway maps that were associated with the fungal balls group. Figure 3a showed all matched pathways according to the p values of the pathway enrichment analysis, and pathway impact values of the pathway topology analysis generated by MetPA. It indicated that the impacts of glycerophospholipid metabolism and sphingolipid metabolism were most remarkable. Figure 3b presented the complete map involving 4 pathways with significant differences in the fungal ball group. Metabolites with arrows were explored by UPLC-MS and met further screen conditions. Most metabolites from glycerophospholipid metabolism showed a downward trend, whereas those from sphingolipid metabolism presented upward. Tryptophan metabolism and terpenoid backbone biosynthesis were associated with the glycerophospholipid metabolism and sphingolipid metabolism pathway via Acyl-CoA.

Correlations between altered metabolites and clinical characteristics in the fugal ball group

The CT measurements were as follows: (1) the median value of the thickness of the posterior lateral wall of the maxillary sinus in fungal balls was 2.31 (P25, P75, 1.695, 3.718) millimeters; (2) the median highest CT value of the high-density area in the maxillary sinus of fungal balls was 351(P25, P75, 261.4, 385.8) Hounsfield Unit (HU). Spearman correlation coefficient was applied to analyze the median value of the thickness of the posterior lateral wall of the maxillary sinus and the median highest CT value of the high-density area in the maxillary sinus with metabolites, respectively. Levels of phytosphingosine, PE (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0) presented a positive correlation with a median value of the thickness of the posterior lateral wall of the maxillary sinus. At the same time, PC(O-16:0/0:0) was correlated positively with the CT value of the high-density area in the maxillary sinus. For serum biochemical results, dl-Phenylalanine was associated with the concentration of calcium ions (Table3).
Table 3
Spearman correlation coefficients between UPLC-MS detected metabolites of fungal balls and clinical results in patients (p < .03)
Clinical information/Metabolites
Patients’ result (median, P25, P75)
Correlation coefficient
Thickness of the posterior lateral wall of maxillary sinus
2.31 (1.695, 3.718) mm
 
PC(O-16:0/0:0)
 
0.721*
Highest CT value of high-density area in maxillary sinus
351 (261.4, 385.8)HU
 
Phytosphingosine
 
0.699
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
 
0.772*
*The Spearman correlation p-value was illustrated if it is less than 0.03

Discussion

Fungal sinusitis is a typical unilateral lesion in the clinic. It has been reported that the levels of IgA, plasma cells, and lymphocytes in the secretion of fungal sinusitis are elevated [17]. In contrast, other inflammatory cells are not infiltrated, suggesting that mucosal immunity induced by fungal sinus balls plays a vital role in the progression of the disease [17]. In addition to the unilateral soft tissue density, shadow in the imaging examination can also be expressed as sinus wall bone changes. It is undeniable that the content of the sinus in fungal sinusitis (fungal mass, sinus secretion) is related to clinical manifestations. Still, due to technical limitations, few pieces of literature describe the composition of sinus contents and their clinical relationship. In the past few decades, with the development of science and technology and the concept of "omics", metabolomics-related techniques have made possible component analysis for complex samples. In this study, we first explored the metabolic differences of fungal sinusitis using metabolomics and initially linked them with clinical manifestations.
Twenty-six metabolites were found related to the disease. In this study, the vast majority of the molecules with putative identification were lipids. Glycerophospholipids were the most detected metabolites associated with the fungal ball. The cell membrane of fungi is enriched with diverse lipids belonging to the class glycerophospholipids, sphingolipids, and sterols. Glycerophospholipids serve as a stable structural component of biological membranes with sn-3 configuration of the glycerol backbone, playing a pivotal role in regulating transport, signal transduction, and protein function regulation [18]. PC and PE are essential and represent the major components of both cellular and subcellular membranes. The decrease of PC is related to the degradation of microbial cells in a fungal ball. PE can also be formed via calcium-dependent head group exchange with pre-existing phospholipids [19]. This study showed that PE level was positively correlated with osteogenesis but negatively correlated with serum calcium ion level. It is speculated that PE participates in key metabolites of sinus wall bone changes. PE is required for energy-dependent severe substrate accumulation. Sinus wall bone hyperplasia in sinus CT is one of the typical features of fungal rhinosinusitis, and we speculate that it may be related to PE metabolism. However, there is still a lack of in-depth research on its mechanism.
Both phosphatidylserine (PS) and phosphatidylethanolamine (PE) were connected to the diglycerides of the sphingolipid metabolic pathway through metabolic conversion (Fig. 4). The conversion between the three regulates cell differentiation, proliferation, and apoptosis in other diseases, including Alzheimer's disease, atherosclerosis, chronic inflammation, etc. [2022]. The role of the base bridge is to connect the protein on the plasma membrane through sugar. Enrichment of lipids in different cell corners could be attributed to acyl chain remodeling, presented in the pathways in this study [23]. Ceramide, sphingosine, and sphingosine 1-phosphate (S1P) are the primary bioactive mediators of sphingolipid metabolism. S1P might be involved in the immune and inflammatory responses of potent cytokines. These ceramide-rich platforms involve various signaling cascades in immune cells, including B cell activation, bacterial pathogen infection, and release of cytokines during infection; they are also essential in inducing apoptosis [24]. Studies have shown that S1P influences bone remodeling [25]. In this study, the content of S1P increased, suggesting that the expression of S1P is related to the bone changes characteristic of fungal sinusitis. In addition, AhR (aryl hydrocarbon receptor) and IDO1(2,3-dioxygenase 1) have been reported to play a vital role in linking the catabolism of microbial tryptophan and host endogenous tryptophan metabolites to regulatory T cell function in the mucosal region [26]. A positive feedback loop between IDO1 and AhR is necessary to drive the co-evolution of symbiotic fungi with the mammalian immune system and microbiota, host survival under stable inflammatory conditions, and fungal symbiosis to prevent immune dysregulation [27], which is consistent with the non-invasive characteristics of the fungal ball. In this study, tryptophan metabolism can elicit both hyper- and anti-inflammatory effects, regulated by Tenuazonic acid (fungal toxins), but the mechanism requires further research. One of the features of metabolomics research is the capacity to qualitatively and quantitatively investigate the link between metabolites and physiopathological changes in the body. In clinical practice, fungal ball sinusitis has the potential to develop into an invasive condition, which frequently results in a poor prognosis. Individuals with contraindications to general anesthesia who are prone to develop invasive fungal sinusitis may find new therapeutic options according to the metabolite analysis results of this study. By interfering with the creation of sphingolipid metabolism and tryptophan metabolism, this study's analysis of metabolites may reveal fresh techniques for treating the illness. To confirm the findings, the design of future in vitro and in vivo experiments needs to be refined.
We tried to correlate metabolites and imaging. As a principal constituent of the lipid fraction present in the calcification front during normal bone formation, the thickness of the posterior lateral wall of the maxillary sinus was positively correlated with the PC (O-16:0/0:0) level, indicating PC had a boosting effect on osteogenesis. Li et al. found that PC metabolism in human osteoblasts and its metabolites contribute to the growth and mineralization of human osteosarcoma cells through metabolomic studies [28]. PC also could affect the osteogenic transdifferentiation of vascular smooth muscle cells into calcified vascular cells [29]. On the other hand, the highest CT value of the high-density area in the maxillary sinus was positively correlated with phosphatidylethanolamine, a key metabolite in the interconversion of glycerophospholipid metabolism and sphingolipid metabolism to augment inflammatory signaling.
The following limitations exist in this study. Firstly, the metabolomic differences between different groups of fungi were not obtained by diversity analysis of fungi; secondly, the relatively small sample size may have biased the selection. Further studies should include an analysis of microbial community composition and the distribution of large samples.

Conclusion

In this study, we applied UPLC/MS to analyze the metabolic components of fungal balls to speculate metabolic pathways, trying to explain the pathogenesis of the disease from a metabolomics perspective. Dysfunctional glycerophospholipid and sphingolipid metabolism was present in patients with fungal ball sinusitis. Glycerophospholipid and sphingolipid metabolism contributed negligibly to the progression of mucosal and osteitis that arises in fungal ball sinusitis. Future work could explore the relationship between biodiversity and the fungal ball, and new treatment ideas for the disease could be suggested based on these findings.

Acknowledgements

Bing Zhou and Lingyan Liu are co-corresponding authors of this paper.

Declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of Qinhuangdao First Hospital (protocol code 2019A057 and the date of approval was 20/12/2018). Written informed consent has been obtained from the patients to publish this paper. Informed consent to participate was obtained from all participants/subjects.
Not applicable.

Competing interests

The authors have no other funding, financial relationships, or conflicts of interest to disclose. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol. 2007;264(5):461–70.CrossRef Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol. 2007;264(5):461–70.CrossRef
2.
Zurück zum Zitat Thompson GR 3rd, Patterson TF. Fungal disease of the nose and paranasal sinuses. J Allergy Clin Immunol. 2012;129(2):321–6.CrossRef Thompson GR 3rd, Patterson TF. Fungal disease of the nose and paranasal sinuses. J Allergy Clin Immunol. 2012;129(2):321–6.CrossRef
3.
Zurück zum Zitat Dhong HJ, Jung JY, Park JH. Diagnostic accuracy in sinus fungus balls: CT scan and operative findings. Am J Rhinol. 2000;14(4):227–31.CrossRef Dhong HJ, Jung JY, Park JH. Diagnostic accuracy in sinus fungus balls: CT scan and operative findings. Am J Rhinol. 2000;14(4):227–31.CrossRef
4.
Zurück zum Zitat Zinreich SJ, Kennedy DW, Malat J, Curtin HD, Epstein JI, Huff LC, Kumar AJ, Johns ME, Rosenbaum AE. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology. 1988;169(2):439–44.CrossRef Zinreich SJ, Kennedy DW, Malat J, Curtin HD, Epstein JI, Huff LC, Kumar AJ, Johns ME, Rosenbaum AE. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology. 1988;169(2):439–44.CrossRef
5.
Zurück zum Zitat Nomura K, Asaka D, Nakayama T, Okushi T, Matsuwaki Y, Yoshimura T, Yoshikawa M, Otori N, Kobayashi T, Moriyama H. Sinus fungus ball in the Japanese population: clinical and imaging characteristics of 104 cases. Int J Otolaryngol. 2013;2013: 731640.CrossRef Nomura K, Asaka D, Nakayama T, Okushi T, Matsuwaki Y, Yoshimura T, Yoshikawa M, Otori N, Kobayashi T, Moriyama H. Sinus fungus ball in the Japanese population: clinical and imaging characteristics of 104 cases. Int J Otolaryngol. 2013;2013: 731640.CrossRef
6.
Zurück zum Zitat Den Beste KA, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis. Int Forum Allergy Rhinol. 2013;3(1):19–25.CrossRef Den Beste KA, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis. Int Forum Allergy Rhinol. 2013;3(1):19–25.CrossRef
7.
Zurück zum Zitat Nyunt TPK, Mullol J, Snidvongs K. Immune response to fungi in diabetic patients with invasive fungal rhinosinusitis. Asian Pac J Allergy Immunol. 2020;38(4):233–8.PubMed Nyunt TPK, Mullol J, Snidvongs K. Immune response to fungi in diabetic patients with invasive fungal rhinosinusitis. Asian Pac J Allergy Immunol. 2020;38(4):233–8.PubMed
8.
Zurück zum Zitat Shin SH, Ye MK, Kim YH, Kim JK. Role of TLRs in the production of chemical mediators in nasal polyp fibroblasts by fungi. Auris Nasus Larynx. 2016;43(2):166–70.CrossRef Shin SH, Ye MK, Kim YH, Kim JK. Role of TLRs in the production of chemical mediators in nasal polyp fibroblasts by fungi. Auris Nasus Larynx. 2016;43(2):166–70.CrossRef
9.
Zurück zum Zitat Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME, et al. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell. 2022;185(4):614–29.CrossRef Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME, et al. An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell. 2022;185(4):614–29.CrossRef
10.
Zurück zum Zitat Challapalli SD, McKee S, Luong AU. The role of fungus in the pathogenesis of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2022;30(1):58–62.CrossRef Challapalli SD, McKee S, Luong AU. The role of fungus in the pathogenesis of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2022;30(1):58–62.CrossRef
11.
Zurück zum Zitat Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263–9.CrossRef Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263–9.CrossRef
12.
Zurück zum Zitat Wang X, Sun H, Zhang A, Wang P, Han Y. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci. 2011;34(24):3451–9.CrossRef Wang X, Sun H, Zhang A, Wang P, Han Y. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci. 2011;34(24):3451–9.CrossRef
13.
Zurück zum Zitat Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopic sinus surgery. Theory and diagnostic evaluation. Arch Otolaryngol. 1985;111(9):576–82.CrossRef Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopic sinus surgery. Theory and diagnostic evaluation. Arch Otolaryngol. 1985;111(9):576–82.CrossRef
14.
Zurück zum Zitat Govindaraj S, Adappa ND, Kennedy DW. Endoscopic sinus surgery: evolution and technical innovations. J Laryngol Otol. 2010;124(3):242–50.CrossRef Govindaraj S, Adappa ND, Kennedy DW. Endoscopic sinus surgery: evolution and technical innovations. J Laryngol Otol. 2010;124(3):242–50.CrossRef
15.
Zurück zum Zitat Ye T, Hwang PH, Huang Z, Huang Q, Xian J, Li C, Zhou B. Frontal ostium neo-osteogenesis and patency after Draf III procedure: a computer-assisted study. Int Forum Allergy Rhinol. 2014;4(9):739–44.CrossRef Ye T, Hwang PH, Huang Z, Huang Q, Xian J, Li C, Zhou B. Frontal ostium neo-osteogenesis and patency after Draf III procedure: a computer-assisted study. Int Forum Allergy Rhinol. 2014;4(9):739–44.CrossRef
16.
Zurück zum Zitat Zhang X, Ye T, Huang Z, Huang Q, Xian J, Li J, Zhou B. Clinical predictors of frontal ostium restenosis after draf 3 procedure for refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2018;32(4):287–93.CrossRef Zhang X, Ye T, Huang Z, Huang Q, Xian J, Li J, Zhou B. Clinical predictors of frontal ostium restenosis after draf 3 procedure for refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2018;32(4):287–93.CrossRef
17.
Zurück zum Zitat Park HJ, Seoh JY, Han KH, Moon KR, Lee SS. The role of mucosal immunity in fungus ball of the paranasal sinuses. Acta Otolaryngol. 2012;132(Suppl 1):S58-62.CrossRef Park HJ, Seoh JY, Han KH, Moon KR, Lee SS. The role of mucosal immunity in fungus ball of the paranasal sinuses. Acta Otolaryngol. 2012;132(Suppl 1):S58-62.CrossRef
18.
Zurück zum Zitat Sant DG, Tupe SG, Ramana CV, Deshpande MV. Fungal cell membrane-promising drug target for antifungal therapy. J Appl Microbiol. 2016;121(6):1498–510.CrossRef Sant DG, Tupe SG, Ramana CV, Deshpande MV. Fungal cell membrane-promising drug target for antifungal therapy. J Appl Microbiol. 2016;121(6):1498–510.CrossRef
19.
Zurück zum Zitat Bjerve KS. Phospholipid substrate-specificity of the l-serine base-exchange enzyme in rat liver microsomal fraction. Biochem J. 1984;219(3):781–4.CrossRef Bjerve KS. Phospholipid substrate-specificity of the l-serine base-exchange enzyme in rat liver microsomal fraction. Biochem J. 1984;219(3):781–4.CrossRef
20.
Zurück zum Zitat Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, O’Brien R, Pletnikova O, Troncoso JC, Toledo J, et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 2018;15(1): e1002482.CrossRef Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, O’Brien R, Pletnikova O, Troncoso JC, Toledo J, et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 2018;15(1): e1002482.CrossRef
21.
Zurück zum Zitat Liu P, Zhu W, Chen C, Yan B, Zhu L, Chen X, Peng C. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 2020;247: 117443.CrossRef Liu P, Zhu W, Chen C, Yan B, Zhu L, Chen X, Peng C. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 2020;247: 117443.CrossRef
22.
Zurück zum Zitat Norris GH, Blesso CN. Dietary and endogenous sphingolipid metabolism in chronic inflammation. Nutrients. 2017;9(11):1180.CrossRef Norris GH, Blesso CN. Dietary and endogenous sphingolipid metabolism in chronic inflammation. Nutrients. 2017;9(11):1180.CrossRef
23.
Zurück zum Zitat Shilovsky GA, Putyatina TS, Ashapkin VV, Yamskova OV, Lyubetsky VA, Sorokina EV, Shram SI, Markov AV, Vyssokikh MY. Biological diversity and remodeling of cardiolipin in oxidative stress and age-related pathologies. Biochemistry. 2019;84(12):1469–83.PubMed Shilovsky GA, Putyatina TS, Ashapkin VV, Yamskova OV, Lyubetsky VA, Sorokina EV, Shram SI, Markov AV, Vyssokikh MY. Biological diversity and remodeling of cardiolipin in oxidative stress and age-related pathologies. Biochemistry. 2019;84(12):1469–83.PubMed
24.
Zurück zum Zitat Henry B, Ziobro R, Becker KA, Kolesnick R, Gulbins E. Acid sphingomyelinase. Handb Exp Pharmacol. 2013;215:77–88.CrossRef Henry B, Ziobro R, Becker KA, Kolesnick R, Gulbins E. Acid sphingomyelinase. Handb Exp Pharmacol. 2013;215:77–88.CrossRef
25.
Zurück zum Zitat Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073.CrossRef Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073.CrossRef
26.
Zurück zum Zitat Korecka A, Dona A, Lahiri S, Tett AJ, Al-Asmakh M, Braniste V, D’Arienzo R, Abbaspour A, Reichardt N, Fujii-Kuriyama Y, et al. Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes. 2016;2:16014.CrossRef Korecka A, Dona A, Lahiri S, Tett AJ, Al-Asmakh M, Braniste V, D’Arienzo R, Abbaspour A, Reichardt N, Fujii-Kuriyama Y, et al. Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes. 2016;2:16014.CrossRef
27.
Zurück zum Zitat Romani L, Zelante T, De Luca A, Iannitti RG, Moretti S, Bartoli A, Aversa F, Puccetti P. Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi. Eur J Immunol. 2014;44(11):3192–200.CrossRef Romani L, Zelante T, De Luca A, Iannitti RG, Moretti S, Bartoli A, Aversa F, Puccetti P. Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi. Eur J Immunol. 2014;44(11):3192–200.CrossRef
28.
Zurück zum Zitat Li Z, Wu G, van der Veen JN, Hermansson M, Vance DE. Phosphatidylcholine metabolism and choline kinase in human osteoblasts. Biochim Biophys Acta. 2014;1841(6):859–67.CrossRef Li Z, Wu G, van der Veen JN, Hermansson M, Vance DE. Phosphatidylcholine metabolism and choline kinase in human osteoblasts. Biochim Biophys Acta. 2014;1841(6):859–67.CrossRef
29.
Zurück zum Zitat Vickers KC, Castro-Chavez F, Morrisett JD. Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells. Atherosclerosis. 2010;211(1):122–9.CrossRef Vickers KC, Castro-Chavez F, Morrisett JD. Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells. Atherosclerosis. 2010;211(1):122–9.CrossRef
Metadaten
Titel
Analysis of metabolites of fungal balls in the paranasal sinuses
verfasst von
Xiaoqing Zhang
Na Zhang
Qian Huang
Shunjiu Cui
Lingyan Liu
Bing Zhou
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2022
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07710-x

Weitere Artikel der Ausgabe 1/2022

BMC Infectious Diseases 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.